Verifying the performance characteristics of the TEG5000 thromboelastogram in the clinical laboratory

R. C. Gosselin, E. E. Estacio, J. Y. Song, Denis M Dwyre

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: To verify the manufacturer performance claims of the TEG5000 with traditional laboratory methods. Materials and methods: Samples were concurrently measured using the TEG5000 analyzer and either PT, APTT, fibrinogen, factor activities, platelet count, or platelet function testing using whole blood or platelet-rich plasma methods. Results: Within-run imprecision yielded coefficient of variation (CV) of <5%. There was no correlation of PT or APTT with R time. Only Factor VIII and factor XII activity significantly correlated with R time. There was significant correlation between k and angle with FBG, PLT count, and factor levels. There was weak inverse correlation between angle results and measures of platelet function. All laboratory methods were significantly correlated with MA. There were significant differences between citrated whole blood and fresh citrated plasma for angle and MA, and between fresh and frozen plasma for R time and MA. We demonstrated a high % inhibition noted with normal, drug naïve donors, especially with ADP PLT mapping (50% inhibition), but less so with AA PLT mapping (20% inhibition). For TEG platelet mapping, 19/22 (86.3%) and 17/22 (77.3%) results were concordant with traditional aggregation results. Conclusion: We demonstrated both the lack of, and strong correlation between laboratory tests and the TEG parameters.

Original languageEnglish (US)
Pages (from-to)183-192
Number of pages10
JournalInternational Journal of Laboratory Hematology
Volume38
Issue number2
DOIs
StatePublished - Apr 1 2016

Fingerprint

Clinical laboratories
Platelets
Blood Platelets
Plasmas
Factor XII
Blood
Platelet-Rich Plasma
Factor VIII
Platelet Count
Adenosine Diphosphate
Fibrinogen
Agglomeration
Pharmaceutical Preparations
Testing

Keywords

  • Factor activity
  • Fibrinogen
  • Platelet function
  • Prothrombin time and activated partial thromboplastin times
  • Thromboelastograph
  • Thromboelastograph

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical
  • Hematology

Cite this

Verifying the performance characteristics of the TEG5000 thromboelastogram in the clinical laboratory. / Gosselin, R. C.; Estacio, E. E.; Song, J. Y.; Dwyre, Denis M.

In: International Journal of Laboratory Hematology, Vol. 38, No. 2, 01.04.2016, p. 183-192.

Research output: Contribution to journalArticle

@article{9b2212b0f2cf42ff8c591d24c0f96a70,
title = "Verifying the performance characteristics of the TEG5000 thromboelastogram in the clinical laboratory",
abstract = "Objective: To verify the manufacturer performance claims of the TEG5000 with traditional laboratory methods. Materials and methods: Samples were concurrently measured using the TEG5000 analyzer and either PT, APTT, fibrinogen, factor activities, platelet count, or platelet function testing using whole blood or platelet-rich plasma methods. Results: Within-run imprecision yielded coefficient of variation (CV) of <5{\%}. There was no correlation of PT or APTT with R time. Only Factor VIII and factor XII activity significantly correlated with R time. There was significant correlation between k and angle with FBG, PLT count, and factor levels. There was weak inverse correlation between angle results and measures of platelet function. All laboratory methods were significantly correlated with MA. There were significant differences between citrated whole blood and fresh citrated plasma for angle and MA, and between fresh and frozen plasma for R time and MA. We demonstrated a high {\%} inhibition noted with normal, drug na{\"i}ve donors, especially with ADP PLT mapping (50{\%} inhibition), but less so with AA PLT mapping (20{\%} inhibition). For TEG platelet mapping, 19/22 (86.3{\%}) and 17/22 (77.3{\%}) results were concordant with traditional aggregation results. Conclusion: We demonstrated both the lack of, and strong correlation between laboratory tests and the TEG parameters.",
keywords = "Factor activity, Fibrinogen, Platelet function, Prothrombin time and activated partial thromboplastin times, Thromboelastograph, Thromboelastograph",
author = "Gosselin, {R. C.} and Estacio, {E. E.} and Song, {J. Y.} and Dwyre, {Denis M}",
year = "2016",
month = "4",
day = "1",
doi = "10.1111/ijlh.12464",
language = "English (US)",
volume = "38",
pages = "183--192",
journal = "International Journal of Laboratory Hematology",
issn = "1751-5521",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Verifying the performance characteristics of the TEG5000 thromboelastogram in the clinical laboratory

AU - Gosselin, R. C.

AU - Estacio, E. E.

AU - Song, J. Y.

AU - Dwyre, Denis M

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Objective: To verify the manufacturer performance claims of the TEG5000 with traditional laboratory methods. Materials and methods: Samples were concurrently measured using the TEG5000 analyzer and either PT, APTT, fibrinogen, factor activities, platelet count, or platelet function testing using whole blood or platelet-rich plasma methods. Results: Within-run imprecision yielded coefficient of variation (CV) of <5%. There was no correlation of PT or APTT with R time. Only Factor VIII and factor XII activity significantly correlated with R time. There was significant correlation between k and angle with FBG, PLT count, and factor levels. There was weak inverse correlation between angle results and measures of platelet function. All laboratory methods were significantly correlated with MA. There were significant differences between citrated whole blood and fresh citrated plasma for angle and MA, and between fresh and frozen plasma for R time and MA. We demonstrated a high % inhibition noted with normal, drug naïve donors, especially with ADP PLT mapping (50% inhibition), but less so with AA PLT mapping (20% inhibition). For TEG platelet mapping, 19/22 (86.3%) and 17/22 (77.3%) results were concordant with traditional aggregation results. Conclusion: We demonstrated both the lack of, and strong correlation between laboratory tests and the TEG parameters.

AB - Objective: To verify the manufacturer performance claims of the TEG5000 with traditional laboratory methods. Materials and methods: Samples were concurrently measured using the TEG5000 analyzer and either PT, APTT, fibrinogen, factor activities, platelet count, or platelet function testing using whole blood or platelet-rich plasma methods. Results: Within-run imprecision yielded coefficient of variation (CV) of <5%. There was no correlation of PT or APTT with R time. Only Factor VIII and factor XII activity significantly correlated with R time. There was significant correlation between k and angle with FBG, PLT count, and factor levels. There was weak inverse correlation between angle results and measures of platelet function. All laboratory methods were significantly correlated with MA. There were significant differences between citrated whole blood and fresh citrated plasma for angle and MA, and between fresh and frozen plasma for R time and MA. We demonstrated a high % inhibition noted with normal, drug naïve donors, especially with ADP PLT mapping (50% inhibition), but less so with AA PLT mapping (20% inhibition). For TEG platelet mapping, 19/22 (86.3%) and 17/22 (77.3%) results were concordant with traditional aggregation results. Conclusion: We demonstrated both the lack of, and strong correlation between laboratory tests and the TEG parameters.

KW - Factor activity

KW - Fibrinogen

KW - Platelet function

KW - Prothrombin time and activated partial thromboplastin times

KW - Thromboelastograph

KW - Thromboelastograph

UR - http://www.scopus.com/inward/record.url?scp=84957711416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957711416&partnerID=8YFLogxK

U2 - 10.1111/ijlh.12464

DO - 10.1111/ijlh.12464

M3 - Article

C2 - 26847002

AN - SCOPUS:84957711416

VL - 38

SP - 183

EP - 192

JO - International Journal of Laboratory Hematology

JF - International Journal of Laboratory Hematology

SN - 1751-5521

IS - 2

ER -